Mice Lacking the Chemokine Receptor CCR1 Show Increased Susceptibility to Toxoplasma gondii Infection1

Chemokines are critical for the recruitment of effector immune cells to sites of infection. Mice lacking the chemokine receptor CCR1 have defects in neutrophil trafficking and proliferation. In the present study, we tested the susceptibility of CCR1 knockout mice to infection with the obligate intracellular protozoan parasite Toxoplasma gondii. In comparison with parental wild-type mice, CCR1−/− mice exhibited dramatically increased mortality to T. gondii in association with an increased tissue parasite load. No differences were observed in Ag-specific T cell proliferation or in cytokine responses between mutant and wild-type mice. However, the influx of PMNs to the peripheral blood and to the liver were reduced in CCR1−/− mice during early infection. Our results suggest that CCR1-dependent migration of neutrophils to the blood and tissues may have a significant impact in controlling parasite replication.

[1]  E. Denkers,et al.  Human Polymorphonuclear Leukocytes Produce IL-12, TNF-α, and the Chemokines Macrophage-Inflammatory Protein-1α and -1β in Response to Toxoplasma gondii Antigens , 1999, The Journal of Immunology.

[2]  J. Djeu Production of Interferon by Natural Killer Cells , 1983, Clinics in Immunology and Allergy.

[3]  Y. Suzuki,et al.  Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. , 1989, Journal of immunology.

[4]  E. Konishi,et al.  Neutrophil chemotactic factors secreted from Toxoplasma gondii , 1991, Parasitology.

[5]  R. Schreiber,et al.  Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. , 1988, Science.

[6]  J. Damme Interleukin-8 and related chemotactic cytokines , 1994 .

[7]  S. McColl,et al.  Regulation of chemokine gene expression in human peripheral blood neutrophils phagocytosing microbial pathogens. , 1998, Journal of immunology.

[8]  C. Hunter,et al.  Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha , 1994, Infection and immunity.

[9]  H. Broxmeyer,et al.  Dominant Myelopoietic Effector Functions Mediated by Chemokine Receptor CCR1 , 1999, The Journal of experimental medicine.

[10]  C. Hunter,et al.  Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis , 1995, Infection and immunity.

[11]  M. Mitsuyama,et al.  An essential role for endogenous interferon‐γ in the generation of protective T cells against Mycobacterium bovis BCG in mice , 1997, Immunology.

[12]  A. Martella,et al.  Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. , 1993, Clinical immunology and immunopathology.

[13]  A. Sher,et al.  Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. , 1991, Journal of immunology.

[14]  J. Wastling,et al.  Induction of CD4+ and CD8+ T cell responses in efferent lymph responding to Toxoplasma gondii infection: analysis of phenotype and function , 1995, Parasite immunology.

[15]  A. Sher,et al.  Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. de Waal Malefyt,et al.  Functional characterization of human IL-10. , 1992, International archives of allergy and immunology.

[17]  A. Sher,et al.  Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. , 1992, Journal of immunology.

[18]  A R Dunn,et al.  Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. , 1994, Blood.

[19]  Y. Yu,et al.  Prostaglandin E2 stimulates IL-8 gene expression in human colonic epithelial cells by a posttranscriptional mechanism. , 1998, Journal of immunology.

[20]  D B Corry,et al.  Constructing polycompetitor cDNAs for quantitative PCR. , 1993, Journal of immunological methods.

[21]  J. Schwartzman,et al.  A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[22]  R. Cisterna,et al.  Kinetics and Regulation of NK Activity by Interleukin‐2 and Interferon in Acute Toxoplasmosis , 1991, Scandinavian journal of immunology.

[23]  R. McLeod,et al.  Measurement of the efficacy of vaccines and antimicrobial therapy against infection with Toxoplasma gondii. , 2000, International journal for parasitology.

[24]  T. Schall,et al.  Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor , 1993, Cell.

[25]  I. Khan,et al.  IL‐10 mediates immunosuppression following primary infection with Toxoplasma gondii in mice , 1995, Parasite immunology.

[26]  P. Murphy,et al.  Cloning and Differential Tissue-specific Expression of Three Mouse Chemokine Receptor-like Genes, Including the Gene for a Functional Macrophage Inflammatory Protein-1 Receptor (*) , 1995, The Journal of Biological Chemistry.

[27]  Johnson Ll,et al.  Exacerbation of toxoplasmosis in neutrophil-depleted mice. , 1996 .

[28]  I. Khan,et al.  Activation-mediated CD4+ T cell unresponsiveness during acute Toxoplasma gondii infection in mice. , 1996, International immunology.

[29]  Michael H. Kutner Applied Linear Statistical Models , 1974 .

[30]  Y. Suzuki,et al.  Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon , 1990, Infection and immunity.

[31]  H. Broxmeyer,et al.  Impaired Host Defense, Hematopoiesis, Granulomatous Inflammation and Type 1–Type 2 Cytokine Balance in Mice Lacking CC Chemokine Receptor 1 , 1997, The Journal of experimental medicine.

[32]  W. Hancock,et al.  Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. , 2000, The Journal of clinical investigation.

[33]  E. Denkers,et al.  Murine neutrophil stimulation by Toxoplasma gondii antigen drives high level production of IFN-gamma-independent IL-12. , 1999, Journal of immunology.

[34]  T. Standiford,et al.  Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1 alpha , 1993, The Journal of experimental medicine.

[35]  V. Barnett,et al.  Applied Linear Statistical Models , 1975 .

[36]  J. Sternberg,et al.  Nitric oxide mediates suppression of T cell responses in murine Trypanosoma brucei infection , 1992, European journal of immunology.

[37]  K. Seydel,et al.  Epithelial cell-initiated inflammation plays a crucial role in early tissue damage in amebic infection of human intestine. , 1998, Gastroenterology.

[38]  J. Collins,et al.  IFN-gamma is produced by polymorphonuclear neutrophils in human uterine endometrium and by cultured peripheral blood polymorphonuclear neutrophils. , 1998, Journal of immunology.

[39]  B. Dewald,et al.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.

[40]  L. Johnson SCID mouse models of acute and relapsing chronic Toxoplasma gondii infections , 1992, Infection and immunity.

[41]  A. Floreani,et al.  Oxygen-derived free radical production by peripheral blood neutrophils in chronic cholestatic liver diseases. , 1999, Hepato-gastroenterology.

[42]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[43]  J. Boothroyd,et al.  Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction , 1989, Journal of clinical microbiology.

[44]  A. Sher,et al.  Role of IL-12 in the initiation of cell mediated immunity by Toxoplasma gondii and its regulation by IL-10 and nitric oxide. , 1994, The Journal of eukaryotic microbiology.

[45]  I. Khan,et al.  Interleukin-12 enhances murine survival against acute toxoplasmosis , 1994, Infection and immunity.

[46]  P. Puccetti,et al.  An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. , 1997, Journal of immunology.

[47]  A. Sher,et al.  Induction and regulation of host cell-mediated immunity by Toxoplasma gondii. , 1995, Ciba Foundation symposium.

[48]  Y. Suzuki,et al.  Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii , 1996, The Journal of experimental medicine.

[49]  P. Murphy Chemokine receptors: structure, function and role in microbial pathogenesis. , 1996, Cytokine & growth factor reviews.

[50]  A. Sher,et al.  Inducible Nitric Oxide Is Essential for Host Control of Persistent but Not Acute Infection with the Intracellular Pathogen Toxoplasma gondii , 1997, The Journal of experimental medicine.

[51]  A. Luster,et al.  Identification of a mouse eosinophil receptor for the CC chemokine eotaxin. , 1996, Biochemical and biophysical research communications.

[52]  D. Remick,et al.  Cytokines in Health and Disease , 1992 .

[53]  L. Johnson,et al.  Exacerbation of toxoplasmosis in neutrophil-depleted mice. , 1996, Natural immunity.

[54]  G. Trinchieri,et al.  Interleukin‐12 production by human polymorphonuclear leukocytes , 1995, European journal of immunology.

[55]  Barry Halliwell,et al.  Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils , 1998, Nature.

[56]  C. Wilson,et al.  Activity of human blood leukocytes against Toxoplasma gondii. , 1979, The Journal of infectious diseases.